OPEN EDUCATIONAL RESOURCES

UPA PERPUSTAKAAN UNEJ | NPP. 3509212D1000001

  • Home
  • Admin
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}
Image of Drugs and the FDA: Safety, Efficacy, and the Public's Trust
Bookmark Share

Text

Drugs and the FDA: Safety, Efficacy, and the Public's Trust

Mikkael A. Sekeres - Personal Name;

How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.

Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FDA's cancer drug advisory committee—tells the story of how the FDA became the most trusted regulatory agency in the world. It took a series of tragedies and health crises, as well as patient advocacy, for the government to take responsibility for ensuring the efficacy and safety of drugs and medical devices.

Before the FDA existed, drug makers could hawk any potion, claim treatment of any ailment, and make any promise on a label. But, throughout the twentieth century, the government was forced to take increasing action when children were poisoned by contaminated diphtheria and smallpox vaccines, an early antibiotic contained antifreeze, a drug prescribed for morning sickness in pregnancy caused babies to be born disfigured, and access to AIDS drugs was limited to a few clinical trials while thousands died. Sekeres describes all these events against the backdrop of the contentious 2011 hearings on the breast cancer drug Avastin, in which he participated as a panel member. The Avastin hearings, he says, put to the test a century of the FDA's evolution, demonstrating how its system of checks and balances works—or doesn't work.


Availability

No copy data

Detail Information
Series Title
-
Call Number
-
Publisher
: The MIT Press., 2022
Collation
-
Language
English
ISBN/ISSN
9780262371322
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Biomedical Sciences
Specific Detail Info
-
Statement of Responsibility
Mikkael A. Sekeres
Other Information
Cataloger
Kholif Basri
Source
https://direct.mit.edu/books/monograph/5390/Drugs-and-the-FDASafety-Efficacy-and-the-Public-s
Validator
-
Digital Object Identifier (DOI)
-
Journal Volume
-
Journal Issue
-
Subtitle
-
Parallel Title
-
Other version/related

No other version available

File Attachment
  • Drugs and the FDA: Safety, Efficacy, and the Public's Trust
Comments

You must be logged in to post a comment

OPEN EDUCATIONAL RESOURCES

Search

start it by typing one or more keywords for title, author or subject


Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search
Where do you want to share?